Crescent Pharma Limited has issued a recall of one batch of Ramipril 10mg capsules. The recall is being carried out as a precautionary measure following the identification of a potential error at the manufacturing site. The Medicines and Healthcare products Regulatory Agency (MHRA) has been notified of the recall.
Regulatorische Updates23. Aug. 2026•1 Min. Lesezeit
Crescent Pharma Recalls Ramipril 10mg Capsules Batch
Crescent Pharma Limited is recalling a batch of Ramipril 10mg capsules as a precaution due to a possible manufacturing error.
Zusammengestellt vom PharmaCountry-Team · Quelle: MHRA
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen